← Leaderboards
Carey Martin
University Of Maryland Baltimore
$4,594,518
Attributed
$4,594,518
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.7M · FY2015–21$5M$3.8M$2.5M$1.3M$0
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$4,594,518 · 1
By mechanism
N01$4,594,518 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Karen L. Kotloff$76,457,208
- Robert J Bloch$16,742,827
- Karen Kotloff$13,373,636
- Myron Max Levine$22,681,817
- Thomas L Pallone$13,901,466
Others in their field
Top investigators on “Vaccines”
- Lawrence Corey · Fred Hutchinson Cancer Center$829,044,908
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$556,540,832
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$515,215,260
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
- Dennis R. Burton · Scripps Research Institute$316,106,418
Research focus
VaccinesContractsDesignEnterotoxigenic Escherichia ColiResourcesRouteConduct Clinical TrialsEvaluationInfectious Disease TreatmentInvestigationPhase I TrialNamed GroupEscherichia Coli VaccinesSpecial Population
Grant awards (3)
Vaccine and Treatment Evaluation Unit: Phase I Trial of an Enterotoxigenic Escherichia coli (ETEC) Vaccine$700,103
N01 · FY2021 · AI · contact PI
Vaccine and Treatment Evaluation Unit: Phase I Trial of an Enterotoxigenic Escherichia coli (ETEC) Vaccine$1,171,593
N01 · FY2017 · AI · contact PI
Phase I Trial of an Enterotoxigenic Escherichia coli (ETEC) Vaccine - VTEU$2,722,822
N01 · FY2015 · AI · contact PI